573 related articles for article (PubMed ID: 24182705)
1. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
2. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
4. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
[TBL] [Abstract][Full Text] [Related]
6. Association of monoclonal gammopathy of undetermined significance and C3 glomerulopathy.
Ekladious A; Bhandari R; Javaid MM
Intern Med J; 2023 Sep; 53(9):1712-1715. PubMed ID: 37665716
[TBL] [Abstract][Full Text] [Related]
7. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
[TBL] [Abstract][Full Text] [Related]
8. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
[TBL] [Abstract][Full Text] [Related]
9. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
10. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Kidney Int; 2018 Jul; 94(1):178-186. PubMed ID: 29729982
[TBL] [Abstract][Full Text] [Related]
11. A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain.
Watanabe H; Osawa Y; Goto S; Habuka M; Imai N; Ito Y; Hirose T; Chou T; Ohashi R; Shimizu A; Ehara T; Shimotori T; Narita I
Pathol Int; 2015 Jan; 65(1):38-42. PubMed ID: 25410550
[TBL] [Abstract][Full Text] [Related]
12. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.
Sethi S; Zand L; Leung N; Smith RJ; Jevremonic D; Herrmann SS; Fervenza FC
Clin J Am Soc Nephrol; 2010 May; 5(5):770-82. PubMed ID: 20185597
[TBL] [Abstract][Full Text] [Related]
13. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Immunoglobulin Deposition Disease and Related Diseases.
Kanzaki G; Okabayashi Y; Nagahama K; Ohashi R; Tsuboi N; Yokoo T; Shimizu A
J Nippon Med Sch; 2019; 86(1):2-9. PubMed ID: 30918151
[TBL] [Abstract][Full Text] [Related]
15. Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.
Chauvet S; Roumenina LT; Aucouturier P; Marinozzi MC; Dragon-Durey MA; Karras A; Delmas Y; Le Quintrec M; Guerrot D; Jourde-Chiche N; Ribes D; Ronco P; Bridoux F; Fremeaux-Bacchi V
Front Immunol; 2018; 9():2260. PubMed ID: 30333829
[TBL] [Abstract][Full Text] [Related]
16. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
18. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?
Bridoux F; Desport E; Frémeaux-Bacchi V; Chong CF; Gombert JM; Lacombe C; Quellard N; Touchard G
Clin J Am Soc Nephrol; 2011 Sep; 6(9):2165-74. PubMed ID: 21784830
[TBL] [Abstract][Full Text] [Related]
19. [IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review].
Adam Z; Feit J; Krejcí M; Pour L; Vasků V; Cermáková Z; Mayer J; Hájek R
Vnitr Lek; 2009 Oct; 55(10):981-90. PubMed ID: 19947244
[TBL] [Abstract][Full Text] [Related]
20. Pathology of glomerular deposition diseases and fibrillary glomerulopathies associated with paraproteinemia and haematopoietic disorder.
Joh K
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S21-4. PubMed ID: 17995523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
